Catalyst Wire Dossier Catalyst Wire Dossier

Pyronaridine Artesunate 3:1 Granule Formulation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pyronaridine Artesunate 3:1 Granule Formulation, covering 2021-11-22 to 2021-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients [Phase 3]

See pricing